Early Stage Triple Negative and HER2 Overexpression Breast Cancers Have Similar Survivals in Chinese Patients

Qin Zhang MD,

Qin Zhang MD

Cangzhou Central Hospital, Cangzhou, Hebei, China

Search for more papers by this author

Shou-Ching Tang MD, PhD, FACP, FRCPC,

Shou-Ching Tang MD, PhD, FACP, FRCPC

Virginia Piper Cancer Institute, Minneapolis, Minnesota, USA

Search for more papers by this author

Hong Liu MD, PhD,

Hong Liu MD, PhD

Second Department of Breast Tumor, Department Of Epidemiology, Tianjin Medical University Cancer Institute and Hospital; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education and Key Laboratory of Cancer Prevention; and Therapy, Tianjin, China

Search for more papers by this author

Qin Zhang MD,

Qin Zhang MD

Cangzhou Central Hospital, Cangzhou, Hebei, China

Search for more papers by this author

Shou-Ching Tang MD, PhD, FACP, FRCPC,

Shou-Ching Tang MD, PhD, FACP, FRCPC

Virginia Piper Cancer Institute, Minneapolis, Minnesota, USA

Search for more papers by this author

Hong Liu MD, PhD,

Hong Liu MD, PhD

Search for more papers by this author

First published: 14 May 2012

https://doi.org/10.1111/j.1524-4741.2012.01241.x

Address Correspondence and reprint requests to: Hong Liu, MD, PhD, Second Department of Breast Tumor, Tianjin Medical University Cancer Institute and Hospital, Huanhuxi Road, Hexi District, Tianjin, China, 300060, or e-mail: [email protected].

Share a link

Email
Wechat
Bluesky

References

1 Brown M, Tsodikov A, Bauer KR, Parise CA, Caggiano V. The role of human epidermal growth factor receptor 2 in the survival of women with estrogen and progesterone receptor-negative, invasive breast cancer: The California Cancer Registry, 1999–2004. Cancer, 2008; 15: 737–47.
10.1002/cncr.23243
Web of Science® Google Scholar
2 Wen-Jin Yin, Jin-Song Lu, Gen-Hong Di, et al. Clinicopathological features of the triple-negative tumors in Chinese breast cancer patients. Breast Cancer Res Treat, 2009; 115: 325–33.
10.1007/s10549-008-0096-0
PubMed Web of Science® Google Scholar
3 Dent R, Trudeau M, Pritchard KI, et al. Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res, 2007; 13: 4429–34.
10.1158/1078-0432.CCR-06-3045
PubMed Web of Science® Google Scholar
4 Jumppanen M, Gruvberger-Saal S, Kauraniemi P, et al. Basal-like phenotype is not associated with patient survival in estrogen-receptor-negative breast cancers (electronic resource). Breast Cancer Res 2007; 9: 151–3.
10.1186/bcr1649
CAS Web of Science® Google Scholar
5 Carey LA, Perou CM, Livasy CA, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA, 2006; 295: 2492–502.
10.1001/jama.295.21.2492
CAS PubMed Web of Science® Google Scholar
6 Abd El-Rehim DM, Ball G, Pinder SE, et al. High-throughput protein expression analysis using tissuemicroarray technology of alarge well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses. Int J Cancer, 2005; 116: 340–50.
10.1002/ijc.21004
CAS PubMed Web of Science® Google Scholar
7 Press M, Bernstein L, Sauter G, et al. Topoisomerase II-alpha Gene Amplification as a Predictor of Responsiveness to Anthracycline Containing Chemotherapy in the Cancer International Research Group 006 Clinical Trial of Trastuzumab (Herceptin) in the Adjuvant Setting. San Antonio, TX: San Antonio Breast Cancer Symposium, 2005; December 8–11, (abstr 1045)
Google Scholar
8 Spitale A, Mazzola P, Soldini D et al. Breast cancer classification according to immunohistochemical markers: clinicopathologic features and short-term survival analysis in a population-based study from the South of Switzerland. Ann Oncol, 2009; 20: 628–35.
10.1093/annonc/mdn675
CAS PubMed Web of Science® Google Scholar

All articles

Early Stage Triple Negative and HER2 Overexpression Breast Cancers Have Similar Survivals in Chinese Patients

References

References

Information

About Wiley Online Library

Help & Support

Opportunities

Connect with Wiley

Early Stage Triple Negative and HER2 Overexpression Breast Cancers Have Similar Survivals in Chinese Patients

References

References

Related

Information